![](https://www.businessmarketinsights.com/assets/img/reports-icon.png)
2028년까지 중남미 뇌암 진단 시장 전망 - 진단 유형(영상 검사, 요추 천자, 생검, 분자 검사 및 기타)별 코로나19 영향 및 지역 분석; 암 유형(청각신경종, 성상세포종, 두개인두종, 신경절신경종, 다형성 교모세포종, 수막종, 뇌막세포종 및 기타); 최종 사용자(병원, 전문 진료소, 외래 수술 센터 등)
시장 소개
뇌암은 종양을 유발하는 뇌 세포의 세포외 성장으로 인해 발생합니다. 종양에는 원발성 뇌종양과 이차성 뇌종양이 있습니다. 원발성 뇌종양은 뇌에서 형성되며 신체의 다른 부위로 퍼지지 않는 반면, 전이라고도 알려진 이차 종양은 신체의 다른 부위에서 시작된 암입니다. 뇌종양은 40가지 주요 유형으로 분류되며, 더 나아가 성장 속도가 느리고 전이 가능성이 낮은 양성 유형과 암성이며 전이 가능성이 높은 악성 유형의 두 가지 주요 그룹으로 더 분류됩니다.
< p>따라서 뇌암 유병률의 증가는 향후 뇌암 진단에 대한 상당한 수요를 창출할 것으로 예상되며, 이는 뇌암 진단 시장을 더욱 주도할 것으로 예상됩니다.COVID? 19 팬데믹은 중남미의 이미 과중하고 자금이 부족한 공공 의료 시스템에 대한 중요한 테스트입니다. 심각한 불평등을 겪고 있습니다. 막대한 인구가 빈곤 속에 살고 있는 중남미는 인구 과밀, 제한된 위생, 식량 불안, 예측할 수 없는 환경 조건으로 인해 광범위한 건강 문제에 지속적으로 직면해 있습니다. 자금이 부족한 국영 병원은 이 지역에서 유일한 의료 서비스 공급원입니다. 브라질은 코로나19로 인해 심각한 상황에 처해 있습니다. 자원 부족으로 인해 이 지역에서 더 많은 과제가 발생하고 있으며, 이는 뇌암 진단 시장의 성장을 방해하고 있습니다. 이러한 모든 요소는 시장 성장을 제한하는 진단 제품 및 서비스의 배포 및 채택을 제한합니다. 그러나 이들 국가에 대한 백신 접종이 계속됨에 따라 이 지역의 다양한 시장 참여자들은 다시 뇌암 진단 개발에 집중하고 제품 유통을 늘릴 것입니다. 따라서 전염병이 뇌암 진단 시장에 미치는 영향은 완화될 것입니다.
시장 개요 및 역학
중남미의 뇌암 진단 시장은 2021년 6,970만 달러에서 2028년 1억 7,580만 달러로 성장할 것으로 예상됩니다. 2021년부터 2028년까지 연평균 성장률(CAGR) 14.1%로 증가할 것으로 추정됩니다. \'원발성 뇌종양\'이라는 용어는 뇌에서 시작되는 종양을 말합니다. 뇌암과 신경계암은 남성과 여성의 사망 원인 중 10번째로 높은 암입니다. 사람의 일생 동안 이런 형태의 종양이 생길 확률은 1% 미만입니다. 대부분의 원발성 중추신경계(CNS) 악성 종양은 뇌종양으로 전체 사례의 85~90%를 차지합니다. 뇌종양은 치명적일 수 있고 삶의 질에 심각한 영향을 미치며 궁극적으로 환자와 그 가족의 삶을 변화시킬 수 있습니다. 게다가, 종양의 조기 발견은 종종 더 많은 치료 옵션을 제공합니다. 첨단 영상 기술로 뇌종양의 위치를 정확히 찾아낼 수 있습니다. 진단 도구에는 자기공명영상(MRI)과 컴퓨터 단층촬영(CT 또는 CAT 스캔)이 포함됩니다. 수술 중 MRI는 수술 중 조직 생검 및 종양 절제를 안내하는 데에도 사용할 수 있습니다. 자기공명분광법(MRS)은 종양의 화학적 특성을 검사하는 데 사용됩니다. 따라서 뇌암의 유병률이 증가함에 따라 뇌암 진단 도구에 대한 수요가 높아지고 있습니다.
주요 시장 부문
진단 유형 측면에서 영상 테스트 부문은 2020년 중남미 뇌암 진단 시장에서 가장 큰 점유율을 차지했습니다. 암 유형 측면에서 다형성 교모세포종 부문은 중남미 뇌에서 가장 큰 점유율을 차지했습니다. 최종 사용자 측면에서 보면 병원 부문이 2020년 중남미 뇌암 진단 시장에서 가장 큰 점유율을 차지했습니다.
나열된 주요 출처 및 회사
준비를 위해 참고한 몇 가지 주요 1차 및 2차 출처 중남미 뇌암 진단 시장에 대한 이 보고서에는 회사 웹사이트, 연례 보고서, 재무 보고서, 국가 정부 문서, 통계 데이터베이스 등이 포함됩니다. 보고서에 나열된 주요 회사로는 Thermo Fisher Scientific Inc., Siemens Healthineers A, GE Healthcare, Biocept, Inc., Koninklijke Philips NV, Canon Medical Systems, Hitachi, Ltd. 및 Neusoft Medical Systems가 있습니다.
이유 보고서 구매
- 남미 및 중미 뇌암 진단 시장 환경을 이해하고 가장 가능성이 높은 시장 부문을 식별합니다. 강력한 수익 보장
- 중남미 뇌암 진단 시장의 끊임없이 변화하는 경쟁 환경을 이해하여 경쟁에서 앞서 나가십시오.
- 남부 지역에서 M&A 및 파트너십 거래를 효율적으로 계획하세요 가장 유망한 예상 판매가 있는 시장 부문을 식별하여 중미 뇌암 진단 시장
- 남중미 뇌암 진단 시장을 형성하는 다양한 부문의 시장 성과에 대한 통찰력 있고 포괄적인 분석을 통해 지식이 풍부한 비즈니스 결정을 내리는 데 도움이 됩니다.
- 2021~2028년 중남미 지역의 다양한 부문별 시장 수익 예측을 얻습니다.
중남미 뇌암 진단 시장 세분화
진단 유형별
- 영상 검사
- MRI
- CT 스캔
- PET
- 생검
- 분자 검사
- 요추 천자
- 기타
암 유형별
< ul>
작성최종 사용자
- 병원
- 전문 진료소
- 외래 수술 센터
- 기타
국가별
- 중남미
- 브라질
- 아르헨티나
- 중남미 나머지 지역
언급된 회사
- Thermo Fisher Scientific Inc.
- Siemens Healthineers A
- GE Healthcare
- Biocept, Inc.
- Koninklijke Philips NV
- Canon Medical Systems
- 히타치(주)
- Neusoft Medical Systems
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Brain Cancer Diagnostics Market – By Diagnostic Type
1.3.2 Brain Cancer Diagnostics Market – By Cancer Type
1.3.3 Brain Cancer Diagnostics Market – By End User
1.3.4 South and Central America Brain Cancer Diagnostics Market – By Country
2. South and Central America Brain Cancer Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. South and Central America Brain Cancer Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Brain Cancer Diagnostics Market- South and Central America PEST Analysis
4.3 Expert Opinion
5. South and Central America Brain Cancer Diagnostics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Increase in Prevalence of Brain Cancer
5.1.2 Rise in Number of Cigarette Smokers
5.2 Market Restraints
5.2.1 High Cost of Diagnosis
5.3 Future Trends
5.3.1 Use of Stimulated Raman Histology (SRH)?Artificial Intelligence (AI) to Enhance Brain Tumor Diagnosis During Surgery
5.4 Impact Analysis
6. Brain Cancer Diagnostics Market – South and Central America Analysis
6.1 South and Central America Brain Cancer Diagnostics Market Revenue Forecasts and Analysis
7. South and Central America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Diagnostic Type
7.1 Overview
7.2 Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)
7.3 Imaging Tests
7.3.1 Overview
7.3.2 Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 MRI
7.3.3.1 Overview
7.3.3.2 MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 CT Scan
7.3.4.1 Overview
7.3.4.2 CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Positron emission tomography (PET)
7.3.5.1 Overview
7.3.5.2 Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Lumbar Puncture
7.4.1 Overview
7.4.2 Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Biopsy
7.5.1 Overview
7.5.2 Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Molecular Testing
7.6.1 Overview
7.6.2 Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. South and Central America Brain Cancer Diagnostics Market Analysis and Forecasts To 2028 – By Cancer Type
8.1 Overview
8.2 Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)
8.3 Astrocytomas
8.3.1 Overview
8.3.2 Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Glioblastoma Multiforme
8.4.1 Overview
8.4.2 Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Ependymomas
8.5.1 Overview
8.5.2 Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Brain Cancer Diagnostics Market Analysis – By End user
9.1 Overview
9.2 Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Specialty Clinics
9.4.1 Overview
9.4.2 Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Ambulatory Surgical Centers
9.5.1 Overview
9.5.2 Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Others
9.6.1 Overview
9.6.2 Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Brain Cancer Diagnostics Market Revenue and Forecasts to 2028 – Geographical Analysis
10.1 South and Central America: Brain Cancer Diagnostics Market
10.1.1 Overview
10.1.2 South and Central America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
10.1.2.1 Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.2 Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Brazil Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1.1 Brazil Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Brazil Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 Brazil Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
10.1.2.3 Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Argentina Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2.1 Argentina Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 Argentina Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 Argentina Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
10.1.2.4 Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.1 Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.2 Rest of South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.3 Rest of South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
10.1.2.4.4 Rest of South and Central America Brain Cancer Diagnostics Market, by Cancer Type– Revenue and Forecast to 2028 (USD Million)
10.1.2.4.5 Rest of South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic on South and Central America Brain Cancer Diagnostics Market
11.1 South and Central America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies Done by the Companies in the Market, (%)
12.1 Organic Developments
12.1.1 Overview
12.2 Inorganic Developments
12.2.1 Overview
13. Company Profiles
13.1 THERMO FISHER SCIENTIFIC INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Siemens Healthineers AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GE Healthcare
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Biocept, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Koninklijke Philips N.V.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Canon Medical Systems
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Hitachi, Ltd.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Neusoft Medical Systems
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Brazil Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 2. Brazil Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 4. Brazil Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 5. Argentina Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 6. Argentina Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Argentina Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 9. Rest of South and Central America Brain Cancer Diagnostics Market, by Diagnostics Type – Revenue and Forecast to 2028 (USD Million)
Table 10. Rest of South and Central America Brain Cancer Diagnostics Market, by Imaging Test – Revenue and Forecast to 2028 (USD Million)
Table 11. Rest of South and Central America Brain Cancer Diagnostics Market, by Cancer Type – Revenue and Forecast to 2028 (USD Million)
Table 12. Rest of South and Central America Brain Cancer Diagnostics Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 13. Organic Developments in the Brain Cancer Diagnostics Market
Table 14. Inorganic Developments in the Brain Cancer Diagnostics Market
Table 15. Glossary of Terms, Brain Cancer Diagnostics Market
LIST OF FIGURES
Figure 1. Brain Cancer Diagnostics Market Segmentation
Figure 2. South and Central America Brain Cancer Diagnostics Market Overview
Figure 3. Imaging Test Segment Held Largest Share of Diagnostic Type in Brain Cancer Diagnostics Market
Figure 4. Brazil is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Brain Cancer Diagnostics Market - South and Central America PEST Analysis
Figure 6. Brain Cancer Diagnostics Market Impact Analysis of Driver and Restraints
Figure 7. South and Central America Brain cancer diagnostics Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Brain Cancer Diagnostics Market Revenue Share, by Diagnostic Type (2020 and 2028)
Figure 9. Imaging Tests: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. MRI: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. CT Scan: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Positron emission tomography (PET): Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Lumbar Puncture: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Biopsy: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Molecular Testing: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Brain Cancer Diagnostics Market Revenue Share, by Cancer Type (2020 and 2028)
Figure 18. Astrocytomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Glioblastoma Multiforme: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Ependymomas: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Brain Cancer Diagnostics Market Revenue Share, by End User (2020 and 2028)
Figure 23. Hospitals: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Specialty Clinics: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Ambulatory Surgical Centers: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Others: Brain Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. South and Central America: Brain Cancer Diagnostics Market, by Key Country – Revenue (2021) (USD Million)
Figure 28. South and Central America: Brain Cancer Diagnostics Market, by Country, 2021 & 2028 (%)
Figure 29. Brazil: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
Figure 30. Argentina: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
Figure 31. Rest of South and Central America: Brain Cancer Diagnostics Market– Revenue and Forecast to 2028 (USD Million)
Figure 32. Impact of COVID-19 Pandemic in South and Central American Country Markets
Figure 33. Growth Strategies Done by the Companies in the Market, (%)
- Thermo Fisher Scientific Inc.
- Siemens Healthineers A
- GE Healthcare
- Biocept, Inc.
- Koninklijke Philips N.V
- Canon Medical Systems
- Hitachi, Ltd.
- Neusoft Medical Systems
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the South and Central America brain cancer diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the South and Central America brain cancer diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth South and Central America market trends and outlook coupled with the factors driving the brain cancer diagnostics market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution